| 摘要 |
An isolated protein (I) e.g., lipid phosphatase protein comprising the same or substantially the same amino acid sequence chosen from a fully defined sequence (S1)-(S5) of 763, 746, 766, 716 and 766 amino acids as given in the specification, a splice variant or its salt, is new. Independent claims are also included for: (1) a nucleic acid (II) which comprises at least one nucleic acid encoding (I); (2) a nucleic acid (III) complementary to (II); (3) a vector (IV) comprising (I), (II) and/or (III); (4) an isolated cell (V) comprising (I), (II), (III) or (IV); (5) a transgenic non-human animal (VI) generated from (V); (6) an antibody (VII) directed against (I); (7) producing (I), (II), or (III) involves cultivating (V) and isolating (I), (II) or (III); and (8) a pharmaceutical composition (VIII) for the treatment of neuronal injuries or diseases, comprising (I), (II), (III), (IV), (VI), (VII), a binding compound isolated by using (I), (II) or (III) and/or a functional interactor isolated by using (I), (II) or (III) and if needed suitable auxiliary substances and/or additives. ACTIVITY : Nootropic; Neuroprotective; Cerebroprotective. No biological data given. MECHANISM OF ACTION : None given. |
